At a glance
- What the study gets you
- Access to the study treatment being tested
- Type of study
- Interventional (receives a drug or procedure)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Contrast Echocardiography (other)
- How long the study runs
- Study runs about 13 months (dates as stated)
- About the drug or intervention
- Contrast Echocardiography — other: Simultaneous contrast echocardiography and cardiac catheterisation for intracardiac pressures in the cardiac catheterisation laboratory
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Testing a treatment
- Ages
- 21 Years to 81 Years
- Who
- All
- Number of participants
- 10
- Started
- 2026-02
- Last checked
- 2026-02
Plain English Summary
What is this study?
- • Testing a new treatment for hfpef - heart failure with preserved ejection fraction
- • NA - 10 participants
- • The goal of this clinical trial is to investigate if ultrasound contrast agents can be used to estimate filling pressures inside the heart in patients with suspected heart disease
Who can take part?
- • Ages 21 Years to 81 Years
- • Diagnosed with hfpef - heart failure with preserved ejection fraction
Where?
- • London - King's College Hospital
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The goal of this clinical trial is to investigate if ultrasound contrast agents can be used to estimate filling pressures inside the heart in patients with suspected heart disease. The main questions it aims to answer are: * Is there a strong correlation between the contrast signal and filling pressures inside the heart? * What is the calibration approach to convert the contrast signal from dB to a measure of pressure in mmHg? Researchers will compare the contrast signal with reference pressures measured using a catheter to see if it can be used to quantify filling pressures inside the heart. Participants will: * Be exposed to a small amount of additional ionising radiation to guide a catheter in position inside the heart for reference pressures * Receive an ultrasound contrast agent at the clinically recommended dose and in line with clinical guidelines, via an intravenous line in their arm * Undergo contrast echocardiography - ultrasound scan of their heart with contrast * Undergo standard echocardiography - ultrasound scan of their heart without contrast
More detail
This study will record ultrasound contrast signals simultaneously with gold standard catheter pressure measurements inside the heart, to enable a direct comparison between the two methods. Complementary ultrasound data will be used to develop a personalised calibration solution to convert the contrast signal in dB to estimated pressure in mmHg. All study procedures will be completed on the same day as the participant's standard of care cardiac catheterisation and no additional study visits will be required.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 21 Years - 81 Years
- Who can join: All genders
Treatment history
Treatments you must have had:
- ✓ a cardiac catheterisation procedure as part of their standard medical care
What the study is looking for
- ✓Participant is willing and able to give agreement to take part to participate in the study
- ✓Patients who require a heart catheterisation procedure as part of their standard medical care
- ✓Good acoustic windows for echocardiography when lying flat on their back
Who cannot take part
- ✗Known previous allergy to SonoVue, used in ultrasound contrast scans
- ✗A hole in their heart that lets blood flow from the right side to the left, skipping the lungs
- ✗Very high blood pressure in the arteries of the lungs (severe lung hypertension)
- ✗Uncontrolled high blood pressure (hypertension)
- ✗Adult respiratory distress syndrome (ARDS; where severe lung inflammation prevents enough oxygen from reaching the body)
See the full criteria
Where Is This Study? (1 UK site)
King's College Hospital
London SE5 9RS, United Kingdom
How to Get in Touch
Amanda Nio, PhD
Sponsor contactCONTACT
Kevin O'Gallagher, MBBS, PhD
Sponsor contactCONTACT
